Latest Insider Transactions at Jazz Pharmaceuticals PLC (JAZZ)
This section provides a real-time view of insider transactions for Jazz Pharmaceuticals PLC (JAZZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Jazz Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Jazz Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 04
2020
|
Paul L Berns Director |
SELL
Open market or private sale
|
Direct |
4,691
-11.43%
|
$698,959
$149.21 P/Share
|
|
Nov 03
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,500
-0.75%
|
$385,000
$154.0 P/Share
|
|
Nov 02
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.3%
|
$145,000
$145.13 P/Share
|
|
Nov 02
2020
|
Patrick G Enright Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,929
+24.68%
|
-
|
|
Nov 02
2020
|
Kenneth W O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,249
+42.86%
|
-
|
|
Nov 02
2020
|
Paul L Berns Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,691
+24.53%
|
-
|
|
Oct 01
2020
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
4,500
-1.34%
|
$634,500
$141.94 P/Share
|